You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Sanofi-Aventis in Consumer Health

Sep 2011

Price: US$525

About this Report

About this Report


Euromonitor International's report on Sanofi-Aventis delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.

Company and market share data provide a detailed look at the financial position of Sanofi-Aventis, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Sanofi-Aventis This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Sanofi-Aventis provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Key company facts

Acquisitions in consumer health care drive Sanofi’s sales

Generic competition but strong growth in consumer health care

SWOT: Sanofi-Aventis

Strategic objectives and challenges

Competitive Positioning

Sanofi aggressively pursues acquisitions

Acquisitions drive Sanofi growth from 2008

Johnson & Johnson leads pack despite recalls

Market Assessment

Analgesics and VDS underpin Sanofi’s presence

Asia Pacific to increase in importance for Sanofi

Geographic and Category Opportunities

Well positioned in Brazil and in Eastern Europe

Build a multinational brand in Icy Hot in topical analgesics

Potential for Chinese expansion through BMP Sunstone

Opportunities in China cough, cold and allergy remedies

Zyrtec and Claritin to face challenge from Allegra

Italy and Australia key Sanofi markets in VDS

Focus on beauty supplements in Chinese market

Acquisitions give Sanofi new brands but regionalism remains

Cortizone strong contender for global brand in medicated skin care

China to lead growth in digestive remedies

Brand Strategy

Competition heats up for Dorflex

Maalox grows in the emerging markets

Doliprane reliant on French market

Operations

Operations

Recommendations

International expansion should remain the priority

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!